已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate Cancer

医学 前列腺癌 骨痛 耐火材料(行星科学) 骨转移 毒性 乳腺癌 癌症 缓和医疗 内科学 泌尿科 外科 胃肠病学 天体生物学 物理 护理部
作者
Jie Yuan,Congjin Liu,Xingdang Liu,Yuankai Wang,Dayu Kuai,Guangming Zhang,John J. Zaknun
出处
期刊:Clinical Nuclear Medicine [Lippincott Williams & Wilkins]
卷期号:38 (2): 88-92 被引量:75
标识
DOI:10.1097/rlu.0b013e318279bf4d
摘要

(177)Lu-labeled ethylenediamine-N,N,N',N'-tetrakis methylene phosphonic acid ((177)Lu-EDTMP), was used to palliate metastatic bone pain as a new bone-seeking radiopharmaceutical. In this phase II study, we assessed the efficacy and safety of (177)Lu-EDTMP for bone pain palliation in patients with breast cancer and hormone refractory prostate cancer with bone metastases.Sixteen patients were enrolled in the trial and were subsequently divided into 2 groups, the low-dose group (1295 MBq) and the high dose group (2590 MBq) to determine differences in toxicities and response rates. Pain scores, Karnofsky indices, mobility scores, and requirement of analgesic administration were assessed at 0, 2, 4, 6, 8, and 12 weeks after injection of (177)Lu-EDTMP. Toxicity was assessed by analyzing hemoglobin, leukocyte, and platelet counts.An obvious reduction in the mean pain score was observed at 2 to 6 weeks after the administration of (177)Lu-EDTMP. The rate of complete responses in bone pain palliation was 55% in group 1 and 80% in group 2 at 6 weeks after treatment. Of the 5 patients who required additional analgesics, all were able to reduce or completely stop taking these medications by 4 weeks after therapy. Mean (SD) Karnofsky indices of 58.18 (9.82) (range, 50-70) and 56.00 (8.94) (range, 50-70) at baseline increased to 82.73 (9.05) (range, 60-90) at 6 weeks after (177)Lu-EDTMP treatment in group 1 and 85.00 (5.77) (range, 80-90) at 8 weeks after injection in group 2, respectively. Mobility scores decreased from 2.91 (1.04) (range, 1-4) and 2.80 (0.84) (range, 2-4) at baseline to 1.00 (0.67) (range, 0-2) and 0.50 (0.58) (range, 0-1) at 8 weeks after administration of (177)Lu-EDTMP in groups 1 and 2, respectively, primarily owing to improved mobility. In group 1, 1 patient experienced grade III toxicity in both hemoglobin and platelet counts. No grade IV toxicities were observed. In group 2, there were no grade III or IV toxicities found in hemoglobin, platelets, or leukocytes counts. Moreover, no clinically significant adverse effects were observed, and no significant differences in either efficacy or safety were detected between the 2 dose levels.This study indicated that (177)Lu-EDTMP was an effective and safe treatment for palliation of metastatic bone pain in patients with prostate or breast cancer. A dose of 1295 MBq (35 mCi) was sufficient for bone pain palliation therapy, and doses as high as 2590 MBq (70 mCi) were well tolerated.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张与今完成签到 ,获得积分10
刚刚
给苏打饼干扎眼完成签到,获得积分10
刚刚
xiaohansan完成签到 ,获得积分10
2秒前
LH发布了新的文献求助10
3秒前
ZIYUNI完成签到 ,获得积分10
4秒前
6秒前
annie完成签到,获得积分10
6秒前
醉熏的小小完成签到 ,获得积分10
7秒前
研友_Z6Qrbn完成签到,获得积分10
9秒前
qiying完成签到,获得积分20
9秒前
flora发布了新的文献求助10
13秒前
Yusjus完成签到,获得积分10
14秒前
17秒前
爱你在心口难开完成签到,获得积分10
17秒前
白华苍松发布了新的文献求助10
18秒前
余香的应助被qiying采纳,获得10
19秒前
OK的应助被精明凡双采纳,获得200
20秒前
21秒前
锦城纯契完成签到 ,获得积分10
22秒前
欣欣完成签到 ,获得积分10
25秒前
浪老师完成签到 ,获得积分10
25秒前
Can完成签到 ,获得积分10
26秒前
李密发布了新的文献求助10
26秒前
sunny发布了新的文献求助10
28秒前
成就苞络完成签到,获得积分10
28秒前
无私的寄灵完成签到 ,获得积分10
28秒前
30秒前
小新完成签到,获得积分10
30秒前
爱吃饼干的土拨鼠完成签到,获得积分10
30秒前
动人的亦旋完成签到,获得积分10
30秒前
31秒前
YoroYoshi完成签到,获得积分10
32秒前
CodeCraft的应助被玄枢采纳,获得30
33秒前
背后飞雪发布了新的文献求助10
35秒前
俭朴朝雪发布了新的文献求助10
35秒前
清爽的巧蕊完成签到,获得积分10
35秒前
cc完成签到,获得积分10
35秒前
tso发布了新的文献求助50
37秒前
脑洞疼的应助被梭梭采纳,获得10
38秒前
壬壬爱学习完成签到 ,获得积分10
38秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189960
求助须知:如何正确求助?哪些是违规求助? 9577096
关于积分的说明 21851564
捐赠科研通 7787957
什么是DOI,文献DOI怎么找? 3435853
关于科研通互助平台的介绍 2559902
邀请新用户注册赠送积分活动 2482735